Pharmaceuticals · Pharmaceuticals: Major · NSE: KPL · data 2026-10-30
Kwality Pharmaceuticals Ltd
In plain words
Price: 12.0% below its 52-week high of ₹3,949.
Delivery: 43.1% of traded shares were kept for delivery over the last 10 sessions, against 43.1% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹554 cr |
| Net profit (last 12 months) | ₹81 cr |
| Sales growth, 3 years (yearly) | 26.1% |
| Profit growth, 3 years (yearly) | 51.5% |
Smart-money activity
15/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 10/30: Delivery 46.2% over the last 20 sessions vs 33.2% in the 40 before (1.39x); shares delivered per day 0.6x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Kwality Pharmaceuticals Ltd debt-free?
Its latest reported debt-to-equity ratio is 0.39.
What is Kwality Pharmaceuticals Ltd's P/E ratio?
About 44.5, based on the last 12 months' earnings and a price of ₹3,475.3 (data 2026-10-30).
What is the 52-week high and low of Kwality Pharmaceuticals Ltd?
The 52-week high is ₹3,949 and the 52-week low is ₹1,561.
Similar companies
Gufic Biosciences Limited (GUFICBIO) · Aarti Drugs Limited (AARTIDRUGS) · Zota Health Care Ltd. (ZOTA) · Ind-Swift Laboratories Ltd. (INDSWFTLAB) · Unichem Laboratories Limited (UNICHEMLAB)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open KPL in NSE Scanner →